Kenneth C. Frazier

Director at Eikon Therapeutics · 1 reported transaction in 1 company · latest trade Feb 4, 2026

Their record

Across their whole record, 1 purchase can be measured; 0 did better than the S&P 500 over the next 6 months.

Typical move −35.9%, S&P 500 +9.5% over the same days.


Eikon TherapeuticsEIKN	Bought $2M · 111,111 shares	Feb 4, 2026	S&P 500 +14.0%thru Oct 29

Feb 4, 2026 · EIKN

$2M

S&P 500 +14.0%thru Oct 29

1 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.